The most effective weight-loss compound ever tested
- 24.2% average body weight loss in 48-week Phase 2 trials; the highest ever recorded for any compound
- Triple-action: shuts down appetite, accelerates fat burning, AND reverses fatty liver simultaneously
- Weekly dosing. Minimal muscle loss. Results visible within 4 weeks.
Retatrutide targets three fat-burning hormones simultaneously; GIP, GLP-1, and glucagon. Where semaglutide hits one receptor and tirzepatide hits two, retatrutide activates all three. The results speak for themselves: in Phase 2 clinical trials published in the New England Journal of Medicine, participants lost an average of 24.2% of their body weight in 48 weeks; the highest weight loss ever recorded for any compound in a human trial. The glucagon receptor arm is what sets it apart: it drives the body to burn liver fat, increase energy expenditure, and normalize lipid metabolism in ways that GLP-1 action alone simply cannot achieve. A separate study showed 86% of participants achieved complete liver fat normalization at 48 weeks.
Retatrutide
฿2,600.00
save 6–12% on orders of 3+ vialsA standard dose-response study (8–12 weeks, 3 cohorts) typically requires 3–5 vials. Order 3+ to activate tier pricing.
For research use only. Not for human or veterinary consumption. In-vitro laboratory use only.
Bank Transfer · BTC · ETH · USDC · USDT · SOL
Description
What It Does
- Maximum body weight reduction; the top of the incretin pharmacology hierarchy
- Non-alcoholic fatty liver disease (NAFLD) resolution via glucagon receptor signaling
- Appetite suppression, reduced food intake, and normalized hunger signaling
- Insulin sensitivity, pancreatic function, and lipid profile improvement
- Comparing triple vs. dual vs. single receptor agonism in metabolic research
How to Reconstitute
Allow the vial to equilibrate to room temperature before opening. Reconstitute in sterile water for injection or 0.1% acetic acid at the working concentration required by your assay. Do not vortex; gently swirl or invert the vial until fully dissolved. Aliquot into single-use volumes to avoid repeated freeze-thaw.
Storage
Store lyophilized vials at −20°C in the original sealed container. Protect from moisture and prolonged UV exposure. Lyophilized peptide is stable for up to 24 months when stored correctly. Reconstituted peptide solutions should be stored at −80°C and used within 30 days. Avoid repeated freeze-thaw cycles, which degrade the peptide over time.
What’s Included
- 1 × Retatrutide lyophilized vial ; 10mg
- Batch number and expiry date printed on vial label
- Discreet external packaging with no product name or branding on the exterior
